Search hospitals > Oregon > Portland

Providence Saint Vincent Medical Center

Claim this profile
Portland, Oregon 97225
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Lymphoma
485 reported clinical trials
25 medical researchers
Photo of Providence Saint Vincent Medical Center in PortlandPhoto of Providence Saint Vincent Medical Center in PortlandPhoto of Providence Saint Vincent Medical Center in Portland

Summary

Providence Saint Vincent Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Lymphoma and other specialties. Providence Saint Vincent Medical Center is involved with conducting 485 clinical trials across 603 conditions. There are 25 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.

Area of expertise

1Cancer
Global Leader
Providence Saint Vincent Medical Center has run 120 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Providence Saint Vincent Medical Center has run 83 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Providence Saint Vincent Medical Center

Breast Cancer
Cancer
Gastric Cancer
Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Esophageal Cancer
Bladder Carcinoma
Diffuse Large B-Cell Lymphoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Providence Saint Vincent Medical Center?
Providence Saint Vincent Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Lymphoma and other specialties. Providence Saint Vincent Medical Center is involved with conducting 485 clinical trials across 603 conditions. There are 25 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.
Where is Providence Saint Vincent Medical Center located?
**Providence Saint Vincent Medical Center** - **Address:** 9205 SW Barnes Rd, Portland, OR 97225 - **Directions:** For real-time directions based on current traffic updates, use Waze. For step-by-step guidance, MapQuest is recommended.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Providence Saint Vincent Medical Center, contact a financial counselor at 855-229-6466, available Monday to Friday, 7 a.m. to 5:30 p.m. PT. In-person appointments with a financial counselor are also available, or you can visit a billing office at your local Providence facility.
What insurance does Providence Saint Vincent Medical Center accept?
Providence Saint Vincent Medical Center accepts a wide range of insurance plans, including commercial insurance, managed Medicaid, Medicare Advantage, and Health Insurance Exchange plans. They are contracted with most major insurance carriers, offering in-network rates for high-quality care. Accepted plans include, but are not limited to, Health Net Dual Eligible, LA Care Medicare Advantage, Anthem Blue Cross HMO Covered California, and various Blue Shield and Health Net Covered California plans.
What awards or recognition has Providence Saint Vincent Medical Center received?
Providence St. Vincent Medical Center, located in Portland, Oregon, is a six-time Magnet designated hospital, the highest national honor for professional nursing practice. It has been named one of America's 50 Best Hospitals by Healthgrades for three consecutive years and recognized as a Top 100 hospital by Solucient 10 times. The hospital is part of Providence in Oregon, a comprehensive not-for-profit network including hospitals, health plans, physicians, clinics, and affiliated health services.